Is ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
ALX Oncology (NASDAQ:ALXO) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
ALX Oncology Announces Pricing of Underwritten Offering [Yahoo! Finance]
New Data Demonstrate CD47 Expression Level Helps Predict Response to ALX Oncology's Evorpacept in Combination with Ziihera (zanidatamab-hrii) in Advanced HER2-Positive Breast Cancer [Yahoo! Finance]
ALX Oncology Announces Pricing of Underwritten Offering